Hyphens inks MOU with A*Star's A*ccelerate
The five-year commercialisation deal covers development of products targeting eczema, acne, pigmentary disorders
Add BT as a preferred sourceSingapore
SGX Catalist-listed Hyphens Pharma International Limited signed a Memorendum of Understanding (MOU) with A*Star's commercial arm A*ccelerate, previously known as Exploit Technologies, at the opening ceremony of its corporate headquarters and integrated facility in Singapore on Wednesday.
Lim See Wah, Hyphen Pharma's chairman and CEO, said: "Our new corporate headquarters and integrated facility will not only provide enhanced efficiency and productivity, it will also serve as an oasis for our people to germinate creative and innovative ideas."
TRENDING NOW
The retirement advice that worries me the most
Showdown at Tanglin Club sees new rival slate elected to general committee
Stocks to watch: Mapletree Industrial Trust, The Hour Glass, UI Boustead Reit, Boustead Singapore, Aspial Lifestyle
‘I feel so stupid’: How young Indonesians get stuck on the debt treadmill
